Credit Suisse Sets Outperform Rating, $125 Target On Gilead Story

By: via Benzinga
Gilead Sciences, Inc. (NASDAQ: GILD) share are down 11 percent since January 4. Credit Suisse’s Alethia Young ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.